Dion Brocks, Bsc, BSc(Pharm), PharmD, Ph.D.
Dr. Brocks earned his BSc(general) '79, BSc(Pharm) '82, PharmD'86, and PhD (Pharmaceutical Sciences) '92 degrees from the University of Alberta. Prior to commencing his academic career, Dr Brocks worked as a pharmacist in hospital and community pharmacies in Alberta, and after receipt of his PharmD degree, as Clinical Coordinator at the Rockyview Hospital Pharmacy department in Calgary. He received his doctoral degree in Pharmaceutical Sciences, specializing in Pharmacokinetics, from the University of Alberta in 1993. He was employed by the Department of Drug Metabolism and Pharmacokinetics at SmithKline Beecham Pharmaceutical in Pennsylvania from 1993 to late 1995, after which he took a position as Assistant Professor at the University of Saskatchewan. In 1998, he joined the faculty at the Western University of Health Sciences in Pomona California (suburban Los Angeles) as Associate Professor of Pharmaceutical Sciences. He taught pharmacokinetics and pursued his research interests there until January 2002, when he returned to his alma mater as Associate Professor of Pharmaceutical Sciences. He has served on numerous committees and has served as Assistant Dean of undergraduate admissions and standards from 2005-2010. He is currently a tenured Professor and Associate Dean of Student Affairs in the faculty. Dr. Brocks is a Fellow of the American Foundation for Pharmaceutical Education and of the Canadian Society for Pharmaceutical Sciences.
Dr. Brocks has published over 100 peer-reviewed manuscripts related to pharmacokinetics, and has numerous published abstracts. He is on or has served with the editorial boards of the Journal of Clinical Pharmacology, Biopharmaceutics and Drug Disposition, and the Journal of Pharmacy and Pharmaceutical Sciences. With respect to his current Research Interests, Dr Brocks in interested in the pharmacokinetics and dynamics of drugs. Many of his works have focused on stereoselectivity in the pharmacokinetics of chiral drugs that are administered as equal proportions of two enantiomers (the racemate). These drugs include nonsteroidal anti-inflammatory drugs, anticholinergic drugs and antimalarial drugs. Most of his recent research activity has focused on the effects that elements of the cardiometabolic syndrome, hyperlipidemia and obesity, can have on the pharmacokinetics and pharmacodynamics of drugs. He is also interested in understanding the influence of the intestinal lymphatic system on the pharmacokinetics of substances.
A listing of his works in Pubmed is found here:
Peer-reviewed papers not cited in Pubmed:
HM Al Nebaihi, TS Le, NM Davies, DR Brocks. Liquid Chromatography Tandem Mass Spectrometric Analytical Method for Study of Colchicine in Rats Given Low Doses. Processes 9 (11), 2007
Brocks DR, Lee KC, Tam YK, Weppler CP, Bradley JM. Use of serum theophylline concentrations in pediatric patients. Canadian Journal of Hospital Pharmacy 1987; 40: 119 122.
Brocks DR, Lee KC, Weppler CP, Tam YK. Theophylline rifampin interaction in a pediatric patient. Clinical Pharmacy 1986; 5: 602 4.
D Brocks, Ken Cor. EXPLORING THE RELATIONSHIP BETWEEN APPLICANT ATTRIBUTES AND ACADEMIC MEASURES OF SUCCESS IN A PHARMACY PROGRAM. Chapter 13, in Data Mining and Learning Analytics: Applications in Educational Research, Ed. S El Atia, D Ipperciel Osmar R. Zaïane, 15 September 2016, Wiley, https://doi.org/10.1002/9781118998205.ch13
YA Yáñez, DR Brocks, ML Forrest, and NM Davies. Chapter 13. Pharmacokinetic Behaviors of Orally Administered Drugs.In: Oral Bioavailability. Editor M. Hu and X. Li. Hoboken: Wiley, 2011. pp 183-220.
DR Brocks. Pharmacokinetics in preclinical drug development: An overview. In: Evaluation of Drug Candidates for Preclinical Development: Pharmacokinetics, metabolism, pharmaceutics and toxicology. Editors: C Han, CB Davis and B Wang. Hoboken: Wiley. 2010, pp 11-38.
DR Brocks, M Vakily and R. Mehvar. Stereospecific pharmacokinetics and pharmacodynamics: Selected classes of drugs. Chapter 6. In: Chirality in drug design and development. Editors; IK Reddy and R Mehvar. New York: Marcel Dekker. 2004, pp 191-280.
R Mehvar and DR Brocks. Stereospecific pharmacokinetics and pharmacodynamics: Cardiovascular drugs. Chapter 7. In: Chirality in drug design and development. Editors; IK Reddy and R Mehvar. New York: Marcel Dekker. 2004, pp 281-350.
DR Brocks and F Jamali. The pharmacokinetics of ibuprofen in animals and humans. In: Ibuprofen; A critical bibliographic review. Editor; K.D. Rainsford. London;Taylor and Francis. 1999, pp 87-142.
Dr. Brocks currently teaches in various lectures in following courses: Pharmacy 303 (also coordinates), 610, 615 (also coordinates), 573 and 630
Provides students with fundamental knowledge of pharmacokinetic concepts and their application in devising appropriate patient-specific dosing regimens. Clinical relevance of pharmacokinetics will be explored through the examination of disease states and drug interactions that affect drug concentrations in the body. (Restricted to Pharmacy students.)